HHM Wealth Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

HHM Wealth Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-596	Closed	–	–	626
2020 Q4	$0	Hold	596	–	–	﹤0.01%	578
2020 Q3	$1K	Buy	596 +6	+1%	+$17	﹤0.01%	498
2020 Q2	$2K	Hold	590	–	–	﹤0.01%	464
2020 Q1	$2K	Buy	+590	New	+$1.94K	﹤0.01%	440

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

HHM Wealth Advisors's BMY.RT Position: Q1 2021 in Review

HHM Wealth Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 596 shares.

HHM Wealth Advisors first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $2K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

HHM Wealth Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
HHM Wealth Advisors sold 596 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
HHM Wealth Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
HHM Wealth Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2K in Q2 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on HHM Wealth Advisors's 13F filing for Q1 2021, filed 23 Apr 2021.